5 Myths About Telemedicine That Are Wrong (2026)

Myth 1: Telemedicine Is Not Real Medicine

Telemedicine is regulated medicine. In the UK it is supervised by the CQC and the GMC; in the US by state medical boards; in India by the NMC; in Nigeria by the MDCN; in Kenya by the KMPDC. A legitimate online consultation carries the same clinical obligations and audit standards as an in-person one.

Myth 2: Online Doctors Cannot Prescribe

They can, and do, every day. Electronic prescriptions are standard: the GMC permits online prescribing with appropriate safeguards; NHS England operates the Electronic Prescription Service; India accepts e-prescriptions under NMC guidelines; Brazil uses ICP-Brasil digital signatures. The honest caveat: controlled substances and some categories are restricted, appropriately.

Myth 3: Video Is Worse Than In-Person

For many conditions the evidence is that remote care is non-inferior. A 2023 JAMA Network Open meta-analysis of 56 randomised trials found online cognitive behavioural therapy non-inferior to in-person for depression and anxiety. The TASMINH4 trial showed remotely supervised home blood-pressure monitoring delivered better control than routine clinic care. Quality of care is driven by the clinician and pathway, not the channel.

Myth 4: Older Patients Will Not Use It

NHS Digital data and CMS Medicare utilisation figures both show sustained telehealth use among patients aged 65+, particularly for chronic-condition follow-ups and medication reviews. Uptake is lower than in younger cohorts but not negligible, and it rises sharply when a family member books and joins the consultation.

Myth 5: It Is Only for Mild Illness

Telemedicine routinely supports chronic-condition management (diabetes, hypertension, asthma), mental health (long-term CBT), and specialist second opinions on complex diagnoses. What it is not suitable for is acute emergencies: chest pain, suspected stroke, severe abdominal pain, anaphylaxis. A responsible service tells you so before you pay.